Clin2
NCT06069063Possibly a fitNot yet recruiting

Zafirlukast for cat allergy symptoms

Allergy to Cats

Part of Immune system & allergy clinical trials.

This trial tests if the drug Zafirlukast can prevent allergy symptoms when people with cat allergies are exposed to cat dander. You would visit the clinic, get the drug or a placebo, and then be exposed to cat allergens to see how you react.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
12 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old and do not smoke
  • You have allergic rhinitis (hay fever) triggered by cats
  • You do not live or work with cats
  • You do not take daily medication for moderate to severe asthma
  • You are generally healthy with no serious heart, lung, or other medical conditions
  • Women who can become pregnant must not be pregnant or nursing and must use effective birth control

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06960382Recruiting· Phase 1/Phase 2
Cat allergy immunotherapy with lymph node injections

This trial tests a new way to treat cat allergies by giving tiny injections directly into a lymph node (a part of your immune system), instead of under the skin. It aims to see if this method is safe and can reduce cat allergy symptoms, even in people with asthma.

Zurich
NCT07675811Recruiting· Phase 3
Study of a new treatment for cat allergy related eye symptoms

This trial tests an injectable treatment that may help manage eye allergy symptoms caused by cat allergies. It aims to see if the treatment is safe and effective for adults and children, and includes a controlled cat exposure challenge.

Andover, Massachusetts
NCT00595491Recruiting· Phase 1
Study immune targets in cat and dust-mite allergic airway inflammation

This Phase 1 study looks at how the immune system drives allergic airway inflammation in people with allergic asthma, and compares them with allergic non-asthma and non-allergic healthy volunteers. The goal is to identify immune “signals” and cell “receptors” involved, which may guide better future treatments.

Boston, Massachusetts
NCT07447869Recruiting· Early Phase 1
Lymph Node Exam in Cat Allergy Treatment Study

This study looks at lymph nodes in the neck to understand how the body responds to cat allergy treatments. It may help researchers improve allergy shots or other therapies for people with cat allergies.

Boston, Massachusetts
NCT07114133Enrolling by invitation
Environmental probiotics for cat hair allergies

This study tests whether a special probiotic spray, used in your home, can reduce allergy symptoms in people who are allergic to cats. If you have cat allergies with nasal symptoms and live in a stable home, you may be able to join.

Hangzhou, Zhejiang
NCT07059091Recruiting· Phase 2
Omalizumab for COPD with allergies

This trial tests if omalizumab, an allergy medication, can help people with COPD who have allergies to common indoor triggers like cat, dog, mouse, cockroach, or dust mite. It aims to reduce flare-ups and improve breathing.

Birmingham, Alabama

Hear when a new Allergy to Cats trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.